Lonza Acquires Transfection Systems Maker Amaxa | GenomeWeb
NEW YORK (GenomeWeb News) – Swiss firm Lonza said today that it has acquired cell research products firm amaxa for an undisclosed sum.
Lonza expects the acquisition to strengthen the cell discovery business of its Lonza Bioscience division, which supplies primary cells and serves a similar customer base to that of amaxa. Cologne, Germany-based amaxa’s Nucleofection technology is used to transfer DNA or RNA into cells that are considered difficult to transfect.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.